First-phase insulin secretion has limited impact on postprandial glycemia in subjects with type 2 diabetes: Correlations between hyperglycemic glucose clamp and meal test

Diabetes Technology and Therapeutics

Volumn 12, Issue 2, 2010, Pages 117-123

  Rave, Klaus ^a   Sidharta, Patricia N ^b   Dingemanse, Jasper ^b   Heinemann, Lutz ^a   Roggen, Kerstin ^a  

^a Profil Institut fur Stoffwechselforschung GmbH   (Germany)

^b ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL;

AREA UNDER CURVE; BLOOD GLUCOSE; COHORT STUDIES; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 76449104467     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0103     Document Type: Article

References (22)

1. Diagnosis and classification of diabetes mellitus. Diabetes Care 2007;30(Suppl 1):S42-S47.
2. Curry DL, Bennett LL, Grodsky GM: Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology 1968; 83:572-584.
3. Bruttomesso D, Pianta A, Mari A, Valerio A, Marescotti MC, Avogaro A, Tiengo A, Del Prato S: Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes 1999;48:99-105.
4. Gerich JE: Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes 2002;51(Suppl 1):S117-S121.
5. Bruce DG, Chisholm DJ, Storlien LH, Kraegen EW: Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes 1988; 37:736-744.
6. van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H, Gerich JE: Relative contributions of beta-cell function and tissue insulin sensitivity to fasting and postglucose-load glycemia. Metabolism 2000;49: 1318-1325.
7. Albarrak AI, Luzio SD, Chassin LJ, Playle RA, Owens DR, Hovorka R: Associations of glucose control with insulin sensitivity and pancreatic beta-cell responsiveness in newly presenting type 2 diabetes. J Clin Endocrinol Metab 2002; 87:198-203.
8. Elahi D: In praise of the hyperglycemic clamp. A method for assessment of beta-cell sensitivity and insulin resistance. Diabetes Care 1996;19:278-286.
9. Mitrakou A, Vuorinen-Markkola H, Raptis G, Toft I, Mokan M, Strumph P, Pimenta W, Veneman T, Jenssen T, Bolli G: Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemic clamp. J Clin Endocrinol Metab 1992;75:379-382.
10. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, Corgnati A, Muggeo M: Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 1989;68:374-378.
11. Meneilly GS, Elliott T: Assessment of insulin sensitivity in older adults using the hyperglycemic clamp technique. J Am Geriatr Soc 1998;46:88-91.
12. Bratusch-Marrain PR: [The euglycemic insulin and hyperglycemic clamp technic. Methods for the determination of insulin sensitivity of tissues and glucose sensitivity of the B cell. A review]. Infusionsther Klin Ernahr 1984;11:4-10.
13. WHO Expert Committee on Diabetes Mellitus: second report. World Health Organ Tech Rep Ser 1980;646:1-80.
14. Reaven GM, Brand RJ, Chen YD, Mathur AK, Goldfine I: Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Diabetes 1993; 42:1324-1332.
15. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
16. Sidharta PN, Rave K, Heinemann L, Chiossi E, Krahenbuhl S, Dingemanse J: Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with diabetes mellitus. Br J Clin Pharmacol 2009; 68:502-510.
17. Ahren B, Pacini G: Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 2004;150:97-104.
18. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP: Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993;42:1663-1672.
19. Seltzer HS, Allen EW, Herron AL Jr, Brennan MT: Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 1967;46:323-335.
20. Mari A, Tura A, Pacini G, Kautzky-Willer A, Ferrannini E: Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes. Diabet Med 2008;25:671-677.
21. van HaeftenTW, Dubbeldam S, Zonderland ML, Erkelens DW: Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects: assessments using hyperglycemic glucose clamps and oral glucose tolerance tests. Diabetes Care 1998;21:278-282.
22. Elahi D, Muller DC, McAloon-Dyke M, Jordan DT, Andres R: The effect of age on insulin response and glucose utilization during four hyperglycemic plateaus. Exp Gerontol 1993;28:393-409